Study Summary:
A multicenter, randomized, active-control study to evaluate the cardiovascular safety of febuxostat and allopurinol in subjects with gout and cardiovascular comorbidities.
Qualified Participants Must:
• If male, 50 years of age or older
•
If female, 55 years of age or older
•
Be diagnosed with gout
•
Have a history of major cardiovascular disease (includes stroke, blocked arteries, diabetes)
Qualified Participants May Receive:
Study medication and study-related medical care at no cost and compensation for time and travel.